Musculoskeletal signaling. Tissue repair. Anti-inflammatory cascade research. The most-studied recovery compounds — triple-verified, COA public. For research use only.
Studied across 200+ peer-reviewed preclinical models. Triple-verified. COA public on every batch. For research use only.
Body Protection Compound. Studied across 100+ peer-reviewed preclinical models for musculoskeletal tissue signaling, angiogenesis regulation, and gut epithelium support. For research only.
Thymosin Beta 4 fragment. Studied for cell migration, actin regulation, angiogenesis, and tissue repair signaling across multiple preclinical models. For research only.
BPC-157 (5mg) + TB-500 (5mg). The most-studied musculoskeletal recovery combination in our catalog. Studied for synergistic tissue signaling. For preclinical research only.
Szeto-Schiller peptide 31. Studied for mitochondrial targeting, cardiolipin binding, and oxidative stress modulation in preclinical research. For research only.
Alpha-MSH C-terminal tripeptide. Studied for anti-inflammatory signaling, gut barrier protection, and NF-κB pathway modulation in preclinical models. For research only.
Selective GHRP with minimal cortisol and prolactin impact. Studied for pulsatile GH release, lean tissue signaling, and recovery optimization in preclinical models. For research only.
Get notified when new recovery compounds are verified and added to the catalog.